Download PDF
Thromb Haemost 2017; 117(01): 198-200
DOI: 10.1160/TH16-04-0324
Letters to the Editor
Schattauer GmbH

Capillary blood samples for anti-Xa monitoring of heparin in paediatric patients

Sallyann Ridsdale
1   Department of Haematology, Sheffield Children’s Hospital, Western Bank, Sheffield, UK
,
Victoria Martin
1   Department of Haematology, Sheffield Children’s Hospital, Western Bank, Sheffield, UK
,
Jeanette H. Payne
1   Department of Haematology, Sheffield Children’s Hospital, Western Bank, Sheffield, UK
› Author Affiliations
Further Information

Publication History

Received: 24 April 2016

Accepted after major revision: 20 September 2016

Publication Date:
09 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Kitchen S, Gray E, Mackie I. et al. Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology. Br J Haematol 2014; 166: 830-841.
    CrossrefPubMedGoogle Scholar
  • 2 Monagle P, Chalmers E, Chan A. et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 887S-968S. 3. Manco-Johnson M, Graham D, Valentino L, et al. (2003) Low-molecular-weight heparin dose requirements are age-related through childhood. In: Abstract from ISTH-XIX Congress of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2003; 1 (suppl 1): Abstract P1879
    CrossrefPubMedGoogle Scholar
  • 3 Harenberg J, Giese Ch, Dempfle CE. et al. Monitoring of Heparin and Low molecular Weight Heparin with Capillary and Venous Whole Blood. Thromb Haemost 1988; 60: 377-381.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Massicotte P, Adams M, Marzinotto V. et al. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996; 128: 313-318.
    CrossrefPubMedGoogle Scholar